- Fellowship - Washington University/Barnes-Jewish Hospital (2006-2009), Gastroenterology
- Residency - Washington University School of Medicine (2004-2006), Internal Medicine
- Medical School - UT Southwestern Medical School (1997-2004)
Thomas Kerr, M.D., Ph.D.
- Internal Medicine - Digestive & Liver Diseases
- Liver Transplant Evaluations
- Liver Transplant Medicine
Thomas A. Kerr, M.D., Ph.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. A hepatologist, Dr. Kerr specializes in liver diseases and liver transplant medicine.
He is certified by the American Board of Internal Medicine in internal medicine, gastroenterology, and transplant hepatology.
Originally from Canada, Dr. Kerr earned his medical degree and doctoral research degree at UT Southwestern. He completed an internal medicine residency, a three-year gastroenterology fellowship, and advanced hepatology/liver transplant training at Barnes-Jewish Hospital in St. Louis.
He also holds a bachelor’s degree in biology from Texas Tech University.
Prior to joining the UT Southwestern faculty in 2015, Dr. Kerr served as an Assistant Professor of internal medicine at Washington University School of Medicine in St. Louis.
Dr. Kerr’s research interests include liver cirrhosis, fatty liver disease, hepatitis C, and liver transplantation. He has published a number of scholarly articles, contributed to several books, and is a guest reviewer for the American Journal of Transplantation and Clinical and Translational Gastroenterology.
He also serves as co-investigator on a number of clinical trials focused on chronic liver conditions.
Dr. Kerr is a member of professional organizations that include the American College of Physicians, the American Society of Transplantation, the American Gastroenterological Association, and the American Association for the Study of Liver Diseases.
In 2019, Dr. Kerr was named a Texas Monthly Super Doctor Rising Star. His professional honors also include the 2009 and 2010 Fellow to Faculty Transition Award from the American Gastroenterological Association/Foundation for Digestive Health and Nutrition, as well as the 2006 Knowlton Incentive for Excellence Award from Washington University School of Medicine in St. Louis.
Meet Dr. Kerr
Liver Disease and Transplant Specialist in Dallas
As a hepatologist at UT Southwestern Medical Center, Thomas Kerr, M.D., Ph.D., specializes in evaluating and treating a full range of acute and chronic liver diseases – from hepatitis and cirrhosis to liver failure and pre- and post-transplant care.
A driving force that led Dr. Kerr to focus on liver conditions was seeing just how transformative the right treatment can be.
“While going through my training, I was struck by how a patient who was terribly sick with advanced liver disease could undergo a liver transplant, and then six months or a year later appear completely healthy with an excellent quality of life,” he says.
Fellowship trained, Dr. Kerr has special expertise in liver transplant medicine and in caring for patients with end-stage liver disease, viral hepatitis, and fatty liver disease. He also performs routine colonoscopies and upper gastrointestinal endoscopies.
Strength of a Multidisciplinary Program
Dr. Kerr is board certified in internal medicine, gastroenterology, and transplant hepatology. He’s proud to be part of UT Southwestern’s skilled, multidisciplinary team, which includes experts in every major liver disease.
“Taking care of patients with liver disease requires both a hepatologist and specialists such as surgeons, radiologists, and pathologists,” he says.
“UT Southwestern has an excellent team that can take care of any liver condition that comes up, and we work together to determine the best course of action.”
The strength of the program, Dr. Kerr says, is that it’s made up of clinicians from a variety of backgrounds, all focused on delivering the best possible care.
“Patient care is about making people’s lives better and longer,” he says. “We focus on what’s best for each individual patient.”
- American Gastroenterological Association (2006), Member
- American Association for the Study of Liver Diseases (2009), Member
- American Society of Transplantation (2011), Member
- Dallas County Medical Society (2015), Member
- Texas Monthly Super Doctor Rising Star 2019
- Barry M. Goldwater Undergraduate Fellowship (Texas Tech University) 1995, The Barry Goldwater Scholarship and Excellence in Education Program Foundation
- Alpha Omega Alpha 2004, Medical Honor Society
- Greg Gurtner Resident Research Award 2005, Washington University School of Medicine, St. Louis, MO
- Knowlton Incentive for Excellence Award 2006, Washington University School of Medicine, St. Louis, MO
- Fellow to Faculty Transition Award 2009, American Gastroenterological Association/Foundation for Digestive Health and Nutrition
Transplant Hepatology in The Washington Manual Gastroenterology Subspecialty Consult (Washington Manual Subspecialty Consult), 3rd ed.
Seetharam A.B., Kerr T.A. (2012), Philadelphia, PA, Lippincott Williams & Wilkins
A Gastroenterology Consult in Neurocritical Care
Nguyen Y., Kerr T.A., Azar R. (2009), New York, NY, Cambridge University Press
Gastric Disorders in The Washington Manual Gastroenterology Subspecialty Consult (Washington Manual Subspecialty Consult), 2nd ed.
Kerr T.A. (2008), Philadelphia, PA, Lippincott Williams & Wilkins
- Transplant Hepatology in The Washington Manual Gastroenterology Subspecialty Consult (Washington Manual Subspecialty Consult), 3rd ed.
cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism.
Lund EG, Kerr TA, Sakai J, Li WP, Russell DW The Journal of biological chemistry 1998 Dec 273 51 34316-27
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ Molecular cell 2000 Sep 6 3 507-15
Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis.
Kerr TA, Saeki S, Schneider M, Schaefer K, Berdy S, Redder T, Shan B, Russell DW, Schwarz M Developmental cell 2002 Jun 2 6 713-20
Therapeutic RNA manipulation in liver disease.
Kerr TA, Davidson NO Hepatology (Baltimore, Md.) 2010 Mar 51 3 1055-61
MicroRNAs and liver disease.
Kerr TA, Korenblat KM, Davidson NO Translational research : the journal of laboratory and clinical medicine 2011 Apr 157 4 241-52
Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution.
Kerr TA, Ciorba MA, Matsumoto H, Davis VR, Luo J, Kennedy S, Xie Y, Shaker A, Dieckgraefe BK, Davidson NO Inflammatory bowel diseases 2012 Feb 18 2 344-8
Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain.
Kerr TA, Davidson NO Hepatology (Baltimore, Md.) 2012 Nov 56 5 1995-8
Cysteine sulfinic acid decarboxylase regulation: A role for farnesoid X receptor and small heterodimer partner in murine hepatic taurine metabolism.
Kerr TA, Matsumoto Y, Matsumoto H, Xie Y, Hirschberger LL, Stipanuk MH, Anakk S, Moore DD, Watanabe M, Kennedy S, Davidson NO Hepatology research : the official journal of the Japan Society of Hepatology 2014 Oct 44 10 E218-28
IDO1 metabolites activate ß-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, Newberry RD, Stenson WF, Ciorba MA Gastroenterology 2013 Aug 145 2 416-25.e1-4
More Than a Rash: Recurrent Hepatocellular Carcinoma After Liver Transplantation.
Moraveji S, Pedersen MR, Chandramouli S, Kerr TA, Grant LM, ACG case reports journal 2019 Jul 6 7 e00107
Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer.
Xie Y, Matsumoto H, Nalbantoglu I, Kerr TA, Luo J, Rubin DC, Kennedy S, Davidson NO PloS one 2013 8 6 e67819
Hepatitis C and substance use: new treatments and novel approaches.
North CS, Hong BA, Kerr T Current opinion in psychiatry 2012 May 25 3 206-12
Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility.
Xie Y, Blanc V, Kerr TA, Kennedy S, Luo J, Newberry EP, Davidson NO The Journal of biological chemistry 2009 Jun 284 25 16860-71
Liver volume in the cirrhotic patient: does size matter?
Hagan MT, Sayuk GS, Lisker-Melman M, Korenblat KM, Kerr TA, Chapman WC, Crippin JS Digestive diseases and sciences 2014 Apr 59 4 886-91
- cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism.
- Liver Transplantation
- Hepatitis C
- Fatty Liver
- Liver Transplant Evaluations
- Liver Transplant Medicine
- Liver Disease
Q&A by Dr. Kerr
Showing 2 locations